Pharmaceutical/Biotech

Supply Chain Delivers Healthcare Value in the Real World

As any supply chain professional knows, sourcing is a critical element of effective procurement.

August 27, 2018

Karen Conway, SCB Contributor

As any supply chain professional knows, sourcing is a critical element of effective procurement.

Five Emerging Tech Trends That Blur the Lines Between Human and Machine

The 35 must-watch technologies represented on the Gartner Inc. Hype Cycle for Emerging Technologies, 2018 revealed five distinct emerging technology trends that will blur the lines between humans and machines.

August 21, 2018

Gartner

The 35 must-watch technologies represented on the Gartner Inc. Hype Cycle for Emerging Technologies, 2018 revealed five distinct emerging technology trends that will blur the lines between humans and machines.

Big Tech's New Alliance Is Good News for the Health of A.I.

Some of the biggest tech giants Monday agreed to build health care products that use a common set of standards in order to make it easier to share medical data across hospitals. What’s more, these are open standards and specifications aimed at encouraging “frictionless data exchange.”

August 14, 2018

Fortune

Some of the biggest tech giants Monday agreed to build health care products that use a common set of standards in order to make it easier to share medical data across hospitals. What’s more, these are open standards and specifications aimed at encouraging “frictionless data exchange.”

Regeneron’s Billionaire Founder Battles the Drug Pricing System

Sipping a lemon-flavored VitaminWater at a sprawling complex of laboratories and offices in Tarrytown, New York, Leonard Schleifer, the 66-year-old cofounder of Regeneron Pharmaceuticals, is, as usual, criticizing the pricing practices of other drug companies. (He once told the chief executive of Pfizer: "You're not entitled to a fraction of the GDP.")

July 30, 2018

Forbes

Sipping a lemon-flavored VitaminWater at a sprawling complex of laboratories and offices in Tarrytown, New York, Leonard Schleifer, the 66-year-old cofounder of Regeneron Pharmaceuticals, is, as usual, criticizing the pricing practices of other drug companies. (He once told the chief executive of Pfizer: "You're not entitled to a fraction of the GDP.")

Podcast | Can Big Data Get Too Big?

Are businesses surfing the wave of big data? Or are they drowning in it?

July 27, 2018

Robert J. Bowman, SupplyChainBrain

Yes, Supply Chain Can Power Population Health

"It was the best of times, it was the worst of times.” The opening line of Charles Dickens’ A Tale of Two Cities contrasts the cities of Paris and London during the French Revolution. In many ways, however, those words describe the state of the U.S. healthcare system today.

July 12, 2018

Karen Conway, SCB Contributor

"It was the best of times, it was the worst of times.” The opening line of Charles Dickens’ A Tale of Two Cities contrasts the cities of Paris and London during the French Revolution. In many ways, however, those words describe the state of the U.S. healthcare system today.

Nestlé Suspended From Palm Oil Scheme for Multiple Shortcomings

July 5, 2018

Supply Management

Nestlé has been suspended from the Roundtable on Sustainable Palm Oil (RSPO) for failing to report properly.

Australian States and Retail Chains Ban Single-Use Plastic Bags

July 3, 2018

NPR

To cut down on waste from single-use plastic bags, some of Australia's largest retailers are banning them.

Emergency Rooms Run Out of Vital Drugs, and Patients Are Feeling It

July 2, 2018

The New York Times

George Vander Linde tapped a code into the emergency room’s automated medicine cabinet. A drawer slid open and he flipped the lid, but found nothing inside.